ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 2035

$1.11M Total Retail Price of All Prescriptions

Rank: 30 out of 2035

322 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 18,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

61 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 901 868 1 4
FUROSEMIDE 828 809 2 7
POTASSIUM CHLORIDE 823 789 3 18
HYDROCODONE-ACETAMINOPHEN 687 663 S3 4 2
LISINOPRIL 684 670 5 3
WARFARIN SODIUM 605 525 6 11
BUMETANIDE 599 589 7 79
SIMVASTATIN 564 521 8 1
METOPROLOL TARTRATE 458 438 9 8
DONEPEZIL HCL 451 451 10 24
FENTANYL 446 433 S2 11 53
NAMENDA 411 411 12 37
AMLODIPINE BESYLATE 331 314 13 6
LANTUS SOLOSTAR 303 268 14 66
MIRTAZAPINE 271 271 15 46
DIVALPROEX SODIUM 266 250 16 75
GABAPENTIN 264 257 17 14
IPRATROPIUM-ALBUTEROL 251 245 18 146
PAROXETINE HCL 219 210 19 69
SERTRALINE HCL 219 198 19 23
OMEPRAZOLE 208 207 21 5
METOPROLOL SUCCINATE 208 181 21 16
ISOSORBIDE MONONITRATE ER 204 199 23 32
CITALOPRAM HBR 187 172 24 20
TRAMADOL HCL 185 180 25 19
GLIPIZIDE 183 182 26 54
PREDNISONE 174 170 27 36
DIGOXIN 155 154 28 67
ESCITALOPRAM OXALATE 153 140 29 77
LEVEMIR FLEXPEN 151 151 30 204
MORPHINE SULFATE ER 139 129 S2 31 86
CARVEDILOL 126 106 32 22
LANTUS 124 108 33 40
LEVETIRACETAM 124 89 33 87
RISPERIDONE 123 122 35 68
SODIUM CHLORIDE 123 123 35 216
ALBUTEROL SULFATE 122 120 37 90
ATENOLOL 120 119 38 10
KLOR-CON M20 120 119 38 73
ROPINIROLE HCL 119 119 40 113
NOVOLOG FLEXPEN 115 111 41 133
CARBIDOPA-LEVODOPA 112 112 42 94
ABILIFY 111 111 43 174
ATORVASTATIN CALCIUM 110 103 44 13
TAMSULOSIN HCL 108 94 45 25
PRAVASTATIN SODIUM 102 94 46 17
AVELOX 101 98 47 263
ADVAIR DISKUS 99 97 48 38
FENOFIBRATE 95 83 49 82
GENERLAC 93 93 50 180
ALLOPURINOL 91 91 51 34
PANTOPRAZOLE SODIUM 91 90 51 42
POLYETHYLENE GLYCOL 3350 90 88 53 48
FORTICAL 89 89 54 286
CYMBALTA 87 86 55 59
FAMOTIDINE 87 80 55 71
HYDROCHLOROTHIAZIDE 83 68 57 12
LOSARTAN POTASSIUM 78 77 58 15
MELOXICAM 77 77 59 56
LACTULOSE 77 77 59 96
CLOPIDOGREL 77 77 59 30
PLAVIX 74 73 62 49
LYRICA 73 73 63 89
CEFTRIAXONE 72 72 64 217
DIOVAN 71 71 65 76
CLONIDINE HCL 70 63 66 61
OLANZAPINE 70 61 66 121
LIDODERM 70 70 66 72
CIPROFLOXACIN HCL 67 63 69 63
TRIAMCINOLONE ACETONIDE 66 51 70 142
SPIRIVA 65 65 71 44
TRAZODONE HCL 63 63 72 50
VIMPAT 60 48 73 346
NOVOLOG 58 58 74 95
MORPHINE SULFATE 57 54 S2 75 183
VENLAFAXINE HCL ER 55 54 76 130
ALENDRONATE SODIUM 55 42 76 27
LEXAPRO 53 49 78 260
CLOTRIMAZOLE-BETAMETHASONE 52 48 79 123
OXYBUTYNIN CHLORIDE ER 51 50 80 117
HYDRALAZINE HCL 50 47 81 45
PEN NEEDLE 50 50 81 100
VERAPAMIL ER 50 50 81 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.